Circulation, Vol 68, 883-888, Copyright © 1983 by American Heart Association
WS Pierce
The recent clinical use of a pneumatic artificial heart at the University
of Utah has focused attention on the role of blood pumps in the support of
the circulation. Pneumatically powered assist pumps are now in clinical
trials in patients with profound but reversible heart failure after
open-heart surgery; survival rates as high as 50% in a heretofore lethal
condition have been encouraging. The results of animal studies with the
pneumatic artificial heart suggest that these devices are ready for
clinical trials; the major application is likely to be as a bridge to
cardiac transplantation. Implantable electric motor-driven assist pumps and
artificial hearts are being evaluated in animals as permanent cardiac
support or replacement devices; clinical use is projected to begin late in
this decade. Initially, these devices will be employed in patients with
end-stage cardiac disease who are not suitable candidates for cardiac
transplantation or for whom donor hearts are not available. The
availability of compact blood pumps will offer new forms of therapy to
patients with certain types of profound heart failure.
ARTICLES
Artificial hearts and blood pumps in the treatment of profound heart failure
This article has been cited by other articles:
![]() |
W. S. Pierce Permanent Heart Substitution: Better Solutions Lie Ahead JAMA, February 12, 1988; 259(6): 891 - 891. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |